Trial intelligence / Profile preview

Fengye Kechuangping oral solution (pediatric) in pediatric acute bronchitis

CTR20210397Phase 2Completed

Sponsor
Yusen Pharma
Start
Mar 2021
Countries
1
01

Overview

A Phase 2 trial of Fengye Kechuangping in acute bronchitis, sponsored by Yusen Pharma. Started Mar 2021; status: completed.

02

Drugs

Fengye Kechuangping
03

Conditions

acute bronchitis

Beyond the preview

Go deeper on CTR20210397.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20210397.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call